Access TOC
Download Data
January 2025
The global biotechnology reagents & kits market size is calculated at USD 733.17 billion in 2024, grew to USD 813.38 billion in 2025, and is projected to reach around USD 2,070.55 billion by 2034. The market is expanding at a CAGR of 10.94% between 2024 and 2034. The rising incidences of chronic disorders, increasing investments & collaborations, and growing research and development activities drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Biotechnology research involves various assays and techniques, such as immunohistochemistry, cell culture, ELISA, Western Blot, flow cytometry, protein purification, etc. Reagents and kits are required for performing such experiments in a laboratory. Some common examples of reagents include antibodies, proteins, buffers, enzymes, DNA vectors, controls, and supplies for the preparation, extraction, isolation, purification, labeling, and analysis of nucleic acids.
The burgeoning biotechnology sector globally positively influences the market. The growing research and development activities by numerous research organizations and biotech companies increase the demand for biotechnology kits & reagents. Several government and private organizations provide funding for conducting biotech research, potentiating market growth. Additionally, public-private collaborations and acquisitions boost the market. The growing demand for synthetic biology and increasing healthcare expenditure drive the market. Furthermore, technological advancements and expanding applications of molecular biology augment market growth.
Artificial intelligence (AI) can revolutionize the biotech sector by enhancing research, drug discovery, diagnostics, and personalized medicine. Integrating AI and machine learning (ML) algorithms can aid in the development of reagents & kits. This results in the production of cost-effective and efficient reagents & kits. AI can also help in developing personalized reagents & kits, depending on the experimental needs. AI and ML can streamline the supply chain and distribution of biotech reagents & kits. Additionally, AI technologies can enhance various biotech processes. It can speed up research and drive innovation. AI can also simplify the manufacturing process, leading to reproducibility and eliminating manual errors. Thus, integrating AI and biotech can open new possibilities for scientific discovery and innovation.
Burgeoning Biotech Sector
Biotechnology is a rapidly emerging field with the latest innovations and technological advancements, leading to the expansion of the biotech sector. Biotech finds applications in various sectors, including healthcare, agriculture, environment, and food. The growth of the biotech sector is attributed to robust mergers and acquisitions of biotech companies. The growth is also governed by increasing investments by several government and private organizations. All these factors promote the launch of novel startups globally. The increasing number of biotech startups and companies also boosts market growth. The COVID-19 pandemic significantly raised the demand for biotech innovations. Furthermore, several government organizations support the biotech sector through numerous guidelines and initiatives, thereby fueling market growth. The biotech sector also grows owing to new product launches and suitable regulatory frameworks.
Fluctuating Raw Material Costs and Insufficient Lab Infrastructure
The major challenge of the biotechnology reagents & kits market is the fluctuating raw material costs. The cost of raw materials fluctuates due to supply and demand, and transportation costs rise due to high fuel prices. This makes it difficult for biotech companies to budget for this and can ultimately impact the costs of goods. Another major restraint of the market is the insufficient laboratory infrastructure. Biotech experiments require stringent temperature-controlled environments with advanced facilities. Several research organizations in low- and middle-income countries lack suitable infrastructure to carry out research activities.
Growing Research and Development
The future of the biotechnology reagents & kits market is promising, driven by growing research and development (R&D) activities. The rising incidences and prevalence of chronic disorders necessitate the development of novel treatment regimens and diagnostics. The new drug discovery and development research for several chronic and rare disorders requires the use of biotech methods. Genomics research, such as genetic engineering, DNA sequencing technology, and gene expression also promotes market growth. This fulfills the growing demand for personalized medicines, leading to its development. Moreover, proteomics research also shows a positive influence on the market. The growing R&D activities also contribute to the development of point-of-care diagnostics for faster and more accurate diagnosis of a disease. Integrating advanced technologies streamlines the biotech research process. All these research studies increase the demand for laboratory experiments and, therefore, reagents and kits.
By kit type, the detection kit segment held a dominant presence in the biotechnology reagents & kits market in 2023. Detection kits are kits to test or identify a particular disease or substance. They can detect the substance either quantitatively or qualitatively. The rising incidences of chronic disorders necessitate the use of detection kits. They are generally used for detecting antibodies, proteins, and other substances, resulting in the diagnosis of the disease.
By kit type, the amplification kit segment is expected to grow at the fastest rate in the market during the forecast period. Amplification kits are used to increase the signal intensity of weak staining antibodies or to amplify DNA. The growing research and development activities, especially genomics research, promote the segment’s growth. They are predominantly used in healthcare and forensic analysis.
By technology, the cell culture segment led the global biotechnology reagents & kits market in 2023. Cell culture techniques are used to study the effects of drugs and toxic compounds on the cells and in drug screening and development. The rapidly expanding cellular and molecular biology research increases the demand for cell culture techniques. Additionally, the growing demand for biological therapeutics and the integration of AI in cell culture also augment the segment’s growth.
By technology, the sequencing segment is predicted to witness significant growth in the market over the forecast period. Sequencing techniques such as next-generation sequencing and single-cell genomic sequencing frequently require reagents and kits for multiple experiments. The growing genomics research and rising prevalence of chronic disorders, including cancer and genetic disorders, potentiate the segment’s growth. The increasing demand for personalized medicines and technological advancements drive the latest innovations, increasing the demand for biotech reagents and kits.
By tested parameters, the RNA segment held the largest share of the biotechnology reagents & kits market in 2023. Several applications, such as sequencing, transcriptome analysis, and infectious pathogen testing, require RNA extraction. RNA assays measure gene expression directly from cell and whole blood lysates or tissue homogenates. The growing genomics research and increasing investments propel the segment’s growth. Additionally, RNA-based therapeutics are in high demand to treat and prevent many human diseases and disorders, as they can cure the root cause of the disease instead of treating the symptoms.
By tested parameters, the DNA segment is expected to gain a significant share of the market over the studied period. The measurement of DNA concentration is important for molecular biology analysis and genomics research. DNA is essential in diagnostics, new vaccine development, and cancer therapy. DNA possesses all the unique information of a human and can also be used to predict the disease outcome. It is primarily required in DNA sequencing, polymerase chain reaction, DNA cloning, and gel electrophoresis.
By purpose, the on-site segment dominated the biotechnology reagents & kits market in 2023. The segment’s growth is attributed to the growing demand for point-of-care (PoC) diagnostics. The rising geriatric population and increasing prevalence of chronic disorders promote the use of PoC diagnostics. The COVID-19 pandemic also resulted in a surge in PoC diagnostics demand and use.
By end-use, the healthcare segment registered its dominance over the global biotechnology reagents & kits market in 2023. The rapidly expanding healthcare sector, growing healthcare infrastructure, and favorable reimbursement policies boost the segment’s growth. The growing research and development activities, personalized medicine, and clinical diagnostics accelerate the demand for biotech reagents and kits. The demand also increases due to the rising number of clinical trials globally.
By end-use, the industrial processing segment is anticipated to grow with the highest CAGR in the market during the studied years. Biotech reagents and kits are essential in industrial processing owing to the large-scale manufacturing of antibodies and biologicals. They enable precision, efficiency, and sustainable operations across various sectors, including healthcare and food processing.
North America dominated the global biotechnology reagents & kits market in 2023. The state-of-the-art research and development activities, burgeoning biotech sector, increasing investments & collaborations, favorable government policies, and the presence of key players drive the market. The U.S. is the leading country with the highest biotech funding globally. The U.S. Department of Health and Human Services invested $40 million to strengthen supply chains and expand the role of biomanufacturing for APIs, antibiotics, and other key starting materials. The Government of Canada invested more than $2.2 billion in 40 projects involving biomanufacturing, vaccine, and therapeutics ecosystems. Additionally, the presence of key market players such as Thermo Fisher Scientific, Bio-Techne Corporation, Illumina, etc., holds the major share of the market. Technological advancements also boost market growth.
Asia-Pacific is estimated to show the fastest growth in the biotechnology reagents & kits market over the forecast period. The rising incidences of chronic disorders, growing research and development activities, rising adoption of advanced technologies, favorable government policies, and suitable biotech manufacturing infrastructure drive the market. The Indian Government supports biotech startups through investments. Also, the Make in India policy encourages key biotech players to manufacture biological products locally and also encourages foreign companies to set up their manufacturing plants in India. The market is also driven by new product approvals. In 2023, 87 novel drugs were approved in China, out of which 59 were biologicals, accounting for 67.8% of total drug approval. The increasing number of biotechnology companies in the region also augments market growth. India has around 6,000 biotech startups, while Japan has around 1,200 biotech startups.
Kim Kelderman, President and CEO of Bio-Techne Corporation, commented on its partnership with Thermo Fisher Scientific that its extensive European distribution network and industry expertise will help the company to enhance support for researchers and accelerate scientific discoveries that address some of the most pressing challenges in healthcare today.
By Kit Type
By Technology
By Tested Parameters
By Purpose
By End-Use
By Region
January 2025
December 2024
December 2024
December 2024
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts